Markets › India › NSE › PANACEABIO

Panacea Biotec Ltd

NSE:PANACEABIOHealthcare

₹349.05−2.96%At closeAt close · Mon 19 Oct · ≈ AED 13.49 · Market cap $231.24M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	66.9%	51.8%	39.0%	8.1%	64.3%	22.7%	—	—
Operating margin	5.3%	−7.9%	−23.1%	−2.5%	−10.9%	−5.9%	−5.9%	+0.0 pts
Net margin	−23.9%	163.6%	−7.3%	−0.2%	−1.5%	−0.8%	−0.8%	+0.0 pts
EBITDA margin	14.0%	253.9%	12.3%	7.5%	5.5%	−0.7%	—	—
Return on equity	64.6%	123.0%	−3.9%	−0.1%	−1.0%	−0.6%	−0.6%	−0.0 pts
Return on assets	−12.5%	61.3%	−2.6%	−0.1%	−0.6%	−0.4%	−0.4%	+0.0 pts
Return on capital employed	4.5%	−5.3%	−11.2%	−1.5%	−6.6%	−4.1%	—	—
Debt / equity	−3.6×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.7%
Debt / assets	69.6%	1.9%	1.6%	1.7%	1.7%	1.9%	—	—
Interest coverage	0.2×	−0.3×	−23.8×	−3.9×	−15.6×	−6.2×	—	—
Current ratio	1.1×	1.3×	1.7×	1.6×	1.5×	1.5×	1.5×	+0.0%
Quick ratio	0.8×	1.0×	1.1×	1.0×	0.9×	0.9×	—	—
Cash ratio	0.1×	0.1×	0.1×	0.2×	0.2×	0.2×	0.2×	+0.0%
Asset turnover	0.5×	0.4×	0.4×	0.4×	0.4×	0.5×	—	—
Inventory turnover	1.2×	1.5×	1.4×	1.5×	0.9×	2.6×	—	—
Receivables turnover	6.6×	7.8×	7.3×	9.0×	7.4×	8.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—